New insulin system aims to simplify diabetes management for adults

NCT ID NCT07070830

First seen Nov 01, 2025 · Last updated May 04, 2026 · Updated 25 times

Summary

This study tested different starting doses of insulin using an automated delivery system (Omnipod M with a continuous glucose monitor) in 56 adults with type 2 diabetes. The goal was to see if a simplified setup is safe and helps keep blood sugar in a healthy range. Participants used the system for up to 12 weeks, with an optional 12-week extension.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AccellaCare

    Wilmington, North Carolina, 28401, United States

  • Disease & Glandular Disease Clinic

    San Antonio, Texas, 78229, United States

  • Emory University

    Atlanta, Georgia, 30303, United States

  • Joslin Diabetes Center

    Boston, Massachusetts, 02215, United States

  • MassResearch LLC.

    Waltham, Massachusetts, 02453, United States

  • University of Colorado

    Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.